Literature DB >> 12019127

Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates.

Simon Kilvington1, Reanne Hughes, James Byas, John Dart.   

Abstract

The activities of therapeutic agents and myristamidopropyl dimethylamine (MAPD) against Acanthamoeba strains recalcitrant to medical therapy were studied. MAPD minimum cysticidal concentrations were 6.25 to 25 microg/ml; 10 to 30 microg/ml gave at least a 3-log cyst kill after 6 h, and 50 and 100 microg/ml gave at least a 3-log cyst kill within 2 and 1 h, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019127      PMCID: PMC127201          DOI: 10.1128/AAC.46.6.2007-2009.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Amoebicidal activity of a preserved contact lens multipurpose disinfecting solution compared to a disinfection/neutralisation peroxide system.

Authors:  S L Buck; R A Rosenthal; R L Abshire
Journal:  Cont Lens Anterior Eye       Date:  1998       Impact factor: 3.077

2.  A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.

Authors:  A S Bacon; D G Frazer; J K Dart; M Matheson; L A Ficker; P Wright
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

3.  Acanthamoeba keratitis successfully treated medically.

Authors:  P Wright; D Warhurst; B R Jones
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

4.  Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.

Authors:  D F Larkin; S Kilvington; J K Dart
Journal:  Ophthalmology       Date:  1992-02       Impact factor: 12.079

5.  Oral itraconazole and topical miconazole with débridement for Acanthamoeba keratitis.

Authors:  Y Ishibashi; Y Matsumoto; T Kabata; R Watanabe; S Hommura; K Yasuraoka; K Ishii
Journal:  Am J Ophthalmol       Date:  1990-02-15       Impact factor: 5.258

6.  Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.

Authors:  I G Duguid; J K Dart; N Morlet; B D Allan; M Matheson; L Ficker; S Tuft
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

7.  Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.

Authors:  D Seal; J Hay; C Kirkness; A Morrell; A Booth; A Tullo; A Ridgway; M Armstrong
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

8.  Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide.

Authors:  D Murdoch; T B Gray; R Cursons; D Parr
Journal:  Aust N Z J Ophthalmol       Date:  1998-08

9.  Interaction of the bisbiguanides chlorhexidine and alexidine with phospholipid vesicles: evidence for separate modes of action.

Authors:  J A Chawner; P Gilbert
Journal:  J Appl Bacteriol       Date:  1989-03

10.  A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.

Authors:  M J Elder; S Kilvington; J K Dart
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-03       Impact factor: 4.799

View more
  6 in total

1.  Practice patterns and opinions in the treatment of acanthamoeba keratitis.

Authors:  Catherine E Oldenburg; Nisha R Acharya; Elmer Y Tu; Michael E Zegans; Mark J Mannis; Bruce D Gaynor; John P Whitcher; Thomas M Lietman; Jeremy D Keenan
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

2.  In vitro amoebicidal activity of four Allium species on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells.

Authors:  Zubeyde Akin Polat; Ayse Vural; Bektas Tepe; Ali Cetin
Journal:  Parasitol Res       Date:  2007-02-22       Impact factor: 2.289

3.  Acanthamoeba polyphaga strain age and method of cyst production influence the observed efficacy of therapeutic agents and contact lens disinfectants.

Authors:  Reanne Hughes; Wayne Heaselgrave; Simon Kilvington
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

4.  Cytotoxic activity of N-chlorotaurine on Acanthamoeba spp.

Authors:  Ursula Fürnkranz; Markus Nagl; Waldemar Gottardi; Martina Köhsler; Horst Aspöck; Julia Walochnik
Journal:  Antimicrob Agents Chemother       Date:  2007-11-26       Impact factor: 5.191

Review 5.  Drug Discovery against Acanthamoeba Infections: Present Knowledge and Unmet Needs.

Authors:  Hany M Elsheikha; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Pathogens       Date:  2020-05-22

6.  In Vitro Evaluation of the Inhibitory Effect of Topical Ophthalmic Agents on Acanthamoeba Viability.

Authors:  Wayne Heaselgrave; Anas Hamad; Steven Coles; Scott Hau
Journal:  Transl Vis Sci Technol       Date:  2019-09-25       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.